CIK 0001533040
- Non-accelerated filer
- Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453215903
- Phone
- +1 508-767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $86,928
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Deming David H Director | Purchase | +3,000 | $0.83 | $3K | 61,800 |
| 2026-11-12 | Deming David H Director | Purchase | +9,000 | $0.81 | $7K | 58,800 |
| 2026-11-11 | Deming David H Director | Purchase | +5,200 | $0.84 | $4K | 49,800 |
| 2026-11-10 | Deming David H Director | Purchase | +6,800 | $0.84 | $6K | 44,600 |
Page 1 of 1 · 4 trades